Cambridge Health Alliance Psychiatry

Topics

• Schizophrenia research and treatment 226
• Attention Deficit Hyperactivity Disorder 90
• Child and Adolescent Psychosocial and Emotional Development 54
• Substance Abuse Treatment and Outcomes 52
• Psychedelics and Drug Studies 42
• Mindfulness and Compassion Interventions 38
• Opioid Use Disorder Treatment 37
• Maternal Mental Health During Pregnancy and Postpartum 35
• Cannabis and Cannabinoid Research 34
• Genetic Associations and Epidemiology 31
• Suicide and Self-Harm Studies 28
• Mental Health Treatment and Access 27

Most cited

1. Mapping genomic loci implicates genes and synaptic biology in schizophrenia.

   Nature · 2022 · 2,203 citations · Lynn DeLisi

2. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.

   JAMA · 2023 · 730 citations · Margaret Lanca

3. Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.

   JAMA psychiatry · 2022 · 515 citations · Michael Bogenschutz

4. Rare coding variants in ten genes confer substantial risk for schizophrenia.

   Nature · 2022 · 699 citations · Lynn DeLisi

5. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.

   Nature medicine · 2021 · 652 citations · Michael Bogenschutz

6. MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.

   Nature medicine · 2023 · 298 citations · Michael Bogenschutz

7. The schizophrenia syndrome, circa 2024: What we know and how that informs its nature.